Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy

被引:1
|
作者
Yang, Hyun Kyung [1 ]
Park, Mi-Suk [1 ]
Han, Kyunghwa [2 ,3 ]
Eom, Geonsik [4 ]
Chung, Yong Eun [1 ]
Choi, Jin-Young [1 ]
Bang, Seungmin [5 ]
Kang, Chang Moo [6 ]
Seong, Jinsil [7 ]
Kim, Myeong-Jin [1 ]
机构
[1] Yonsei Univ, Severance Hosp, Dept Radiol, Coll Med, Seoul, South Korea
[2] Yonsei Univ, Res Inst Radiol Sci, Dept Radiol, Coll Med, Seoul, South Korea
[3] Yonsei Univ, Ctr Clin Imaging Data Sci, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Dept Med, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Severance Hosp, Inst Gastroenterol, Dept Internal Med,Coll Med, Seoul, South Korea
[6] Yonsei Univ, Severance Hosp, Pancreatobiliary Canc Ctr, Yonsei Canc Ctr,Dept Surg,Coll Med, Seoul, South Korea
[7] Yonsei Univ, Severance Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea
来源
CANCER RESEARCH AND TREATMENT | 2024年 / 56卷 / 01期
关键词
Pancreatic ductal carcinoma; Prognosis; Neoadjuvant therapy; X-ray computed tomography; CA-19-9; antigen; CONSENSUS STATEMENT; CANCER; LEWIS; CHEMOTHERAPY; RESECTION; TUMOR; PHENOTYPE; CA19-9; SERUM;
D O I
10.4143/crt.2023.586
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Clinical prognostic criteria using preoperative factors were not developed for post-neoadjuvant therapy (NAT) surgery of pancreatic ductal adenocarcinoma (PDAC). We aimed to identify preoperative factors associated with overall survival (OS) in PDAC patients who underwent post-NAT curative-intent surgery and develop risk stratification criteria. Materials and Methods Consecutive PDAC patients who underwent post-NAT curative-intent surgeries between 2007 and 2020 were retrospectively analyzed. Demographic, laboratory, surgical, and histopathologic variables were collected. Baseline, preoperative, and interval changes of computed tomography (CT) findings proposed by the Society of Abdominal Radiology and the American Pancreatic Association were analyzed. Cox proportional hazard analysis was used to select preoperative variables associated with OS. We developed risk stratification criteria composed of the significant preoperative variables, i.e., post-NAT response criteria. We compared the discrimination performance of post-NAT response criteria with that of post-NAT pathological (yp) American Joint Cancer Committee TNM staging system. Results One hundred forty-five PDAC patients were included. Stable or increased tumor size on CT (hazard ratio [HR], 2.58; 95% confidence interval [CI], 1.58 to 4.21; p < 0.001) and elevated preoperative carbohydrate antigen 19-9 (CA19-9) level (HR, 1.98; 95% CI, 1.11 to 3.55; p=0.021) were independent factors of OS. The OS of the patient groups stratified by post-NAT response criteria which combined changes in tumor size and CA19-9 showed significant difference (p < 0.001). Such stratification was comparable to ypTNM staging in discrimination performance (difference of C-index, 0.068; 95% CI, -0.012 to 0.142). Conclusion "Any degree of decrease in tumor size on CT" and CA19-9 normalization or staying normal were independent favorable factors of OS. The combination of the two factors discriminated OS comparably to ypTNM staging.
引用
收藏
页码:247 / 258
页数:12
相关论文
共 50 条
  • [41] Impact of Neoadjuvant Chemoradiotherapy on Postoperative Course after Curative-intent Transthoracic Esophagectomy in Esophageal Cancer Patients
    Bosch, Dirk J.
    Muijs, Christina T.
    Mul, Veronique E. M.
    Beukema, Jannet C.
    Hospers, Geke A. P.
    Burgerhof, Johannes G. M.
    Plukker, John Th M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (02) : 605 - 611
  • [42] A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery
    Yutaka Endo
    Laura Alaimo
    Henrique A. Lima
    Zorays Moazzam
    Francesca Ratti
    Hugo P. Marques
    Olivier Soubrane
    Vincent Lam
    Minoru Kitago
    George A. Poultsides
    Irinel Popescu
    Sorin Alexandrescu
    Guillaume Martel
    Aklile Workneh
    Alfredo Guglielmi
    Tom Hugh
    Luca Aldrighetti
    Itaru Endo
    Timothy M. Pawlik
    Annals of Surgical Oncology, 2023, 30 : 725 - 733
  • [43] A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery
    Endo, Yutaka
    Alaimo, Laura
    Lima, Henrique A.
    Moazzam, Zorays
    Ratti, Francesca
    Marques, Hugo P.
    Soubrane, Olivier
    Lam, Vincent
    Kitago, Minoru
    Poultsides, George A.
    Popescu, Irinel
    Alexandrescu, Sorin
    Martel, Guillaume
    Workneh, Aklile
    Guglielmi, Alfredo
    Hugh, Tom
    Aldrighetti, Luca
    Endo, Itaru
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 725 - 733
  • [44] Surveillance after resection of pancreatic ductal adenocarcinoma with curative intent - a multicenter survey in Germany and review of the literature
    Ettrich, Thomas J.
    Schulte, Lucas A.
    Eitel, Natalie
    Ettrich, Kristin
    Berger, Andreas W.
    Perkhofer, Lukas
    Seufferlein, Thomas
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (07): : 657 - 664
  • [45] Statins potentially improve survival of patients undergoing curative resection for pancreatic ductal adenocarcinoma
    Petermann, D.
    Kefleyesus, A.
    Demartines, N.
    Schaefer, M.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 6 - 7
  • [46] Prognostic Impact of Coagulation Activity in Patients Undergoing Curative Resection for Pancreatic Ductal Adenocarcinoma
    Matsumura, Kazuki
    Hayashi, Hiromitsu
    Uemura, Norio
    Zhao, Liu
    Higashi, Takaaki
    Yamao, Takanobu
    Kitamura, Fumimasa
    Nakao, Yusuke
    Yusa, Toshihiko
    Itoyama, Rumi
    Imai, Katsunori
    Yamashita, Yo-Ichi
    Baba, Hideo
    IN VIVO, 2020, 34 (05): : 2845 - 2850
  • [47] Prevalence of radiologic evidence of metastatic pancreatic ductal adenocarcinoma (PDAC) at first post-operative restaging studies in patients (pts) undergoing pancreatic cancer surgery with curative intent.
    Palacio, Sofia
    Hosein, Peter Joel
    Levi, Joe U.
    Merchan, Jaime R.
    Monge, Jorge
    Portelance, Lorraine
    Reis, Isildinha M.
    Lima, Caio Max S. Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [48] Prognostic stratification in patients with pancreatic ductal adenocarcinoma after curative resection based on preoperative pancreatic contrast-enhanced CT findings
    Li, Dengfeng
    Wang, Leyao
    Cai, Wei
    Liang, Meng
    Ma, Xiaohong
    Zhao, Xinming
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 151
  • [49] Persistent Opioid Use in Women Undergoing Curative-Intent Breast Cancer Surgery in 2020
    McLaughlin, Mean M.
    Mangal, Rohan
    Desai, Anshumi
    Singh, Devinder
    Tadisina, Kashyap
    Catinchi, Juan Melia
    Goel, Neha
    Kesmodel, Susan B.
    Rojas, Kristin
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S100 - S100
  • [50] Patient Preferences for Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
    Hamad, Ahmad
    Crossnohere, Norah
    Ejaz, Aslam
    Tsung, Allan
    Pawlik, Timothy M.
    Sarna, Angela
    Santry, Heena
    Wills, Celia
    Cloyd, Jordan M.
    PANCREAS, 2022, 51 (06) : 657 - 662